SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 396 filers reported holding SEATTLE GENETICS INC in Q3 2020. The put-call ratio across all filers is 0.61 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $70,056,000 | -10.5% | 400,000 | 0.0% | 2.25% | -16.7% |
| Q3 2020 | $78,276,000 | +15.2% | 400,000 | 0.0% | 2.70% | -9.5% |
| Q2 2020 | $67,968,000 | +47.3% | 400,000 | 0.0% | 2.99% | -5.0% |
| Q1 2020 | $46,152,000 | -19.2% | 400,000 | -20.0% | 3.15% | -2.6% |
| Q4 2019 | $57,130,000 | +783.3% | 500,000 | +300.0% | 3.23% | +110.1% |
| Q2 2017 | $6,468,000 | +2.9% | 125,000 | +25.0% | 1.54% | +11.9% |
| Q1 2017 | $6,286,000 | +19.1% | 100,000 | 0.0% | 1.37% | -32.7% |
| Q4 2016 | $5,277,000 | -58.0% | 100,000 | -57.0% | 2.04% | -63.8% |
| Q3 2016 | $12,563,000 | +33.7% | 232,600 | 0.0% | 5.63% | -32.4% |
| Q2 2016 | $9,399,000 | +14.7% | 232,600 | -0.4% | 8.33% | +3.9% |
| Q1 2016 | $8,197,000 | +14.1% | 233,600 | +46.0% | 8.02% | +29.4% |
| Q4 2015 | $7,181,000 | – | 160,000 | – | 6.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 50,060,240 | $5,775,950,000 | 35.57% |
| Lagoda Investment Management, L.P. | 72,969 | $8,419,000 | 9.97% |
| Avidity Partners Management LP | 580,000 | $66,920,000 | 9.25% |
| Arabesque Asset Management Ltd | 14,807 | $1,708,000 | 3.53% |
| Boxer Capital, LLC | 400,000 | $46,152,000 | 3.15% |
| Woodline Partners LP | 364,333 | $42,037,000 | 3.00% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 56,900 | $6,557,000 | 2.99% |
| SECTORAL ASSET MANAGEMENT INC | 107,000 | $12,346,000 | 2.37% |
| Capital International, Inc./CA/ | 1,197,659 | $138,186,000 | 2.33% |
| Bain Capital Public Equity Management II, LLC | 169,641 | $19,573,000 | 2.29% |